SCHEMBL10024643

SCHEMBL10024643

Cc1ccc(N=C2N=C(N)C(=O)C=C2Nc2ccc(C)cc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 8/20 0.43
▸ LMNA P02545 6/20 0.43
▸ SMN1; SMN2 Q16637 3/20 0.43
▸ BLM P54132 2/20 0.43
▸ KDM4E B2RXH2 2/20 0.43
▸ TP53 P04637 2/20 0.43
▸ HTT P42858 2/20 0.43
▸ POLB P06746 2/20 0.43
▸ TDP2 O95551 1/20 0.43
▸ NSD2 O96028 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ CASP3 P42574 1/20 0.43
▸ SENP8 Q96LD8 1/20 0.43
▸ SENP7 Q9BQF6 1/20 0.43
▸ SENP6 Q9GZR1 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ KMT2A Q03164 3/20 0.40
▸ MEN1 O00255 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL497306 0.89 DNM1 (0.36) MAPTLMNASMN1; SMN2BLMKDM4E
SCHEMBL10024649 0.89 DNM1 (0.36) MAPTLMNASMN1; SMN2BLMKDM4E
SCHEMBL497307 0.89 DNM1 (0.36) MAPTLMNASMN1; SMN2BLMKDM4E
SCHEMBL10024646 0.86 DNM1 (0.51) MAPTLMNASMN1; SMN2BLMTP53
SCHEMBL496948 0.86 DNM1 (0.51) MAPTLMNASMN1; SMN2BLMTP53
SCHEMBL496950 0.86 DNM1 (0.51) MAPTLMNASMN1; SMN2BLMTP53
SCHEMBL497179 0.84 MAPT (0.36) MAPTLMNASMN1; SMN2TP53HTT
SCHEMBL497181 0.84 MAPT (0.36) MAPTLMNASMN1; SMN2TP53HTT
SCHEMBL12997213 0.79 CA1 (0.39) MAPTLMNASMN1; SMN2ALDH1A1MAPK1
SCHEMBL15062937 0.79 CYP1A2 (0.30) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8105394-B2 Azomethine direct dyes or reduced precursors of azomethine direct dyes obtained from 2-alkylresorcinols, and hair dyeing process using these dyes or precursors L'OREAL S.A. (FR) 2012-01-31 — — US disclosed
US-20110041262-A1 AZOMETHINE DIRECT DYES OR REDUCED PRECURSORS OF AZOMETHINE DIRECT DYES OBTAINED FROM 2-ALKYLRESORCINOLS, AND HAIR DYEING PROCESS USING THESE DYES OR PRECURSORS L'OREAL S.A (FR) 2011-02-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110041262-A1 AZOMETHINE DIRECT DYES OR REDUCED PRECURSORS OF AZOMETHINE DIRECT DYES OBTAINED FROM 2-ALKYLRESORCINOLS, AND HAIR DYEING PROCESS USING THESE DYES OR PRECURSORS KRT18, AKR1C4, QDPR MAPT 1558/4885LMNA 1236/4885SMN1; SMN2 4825/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback